Cargando…
Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands
Since the 1980s the genetic cause of many hereditary tumor syndromes has been elucidated. As a consequence, carriers of a deleterious mutation in these genes may opt for prenatal diagnoses (PND). We studied the uptake of prenatal diagnosis for five hereditary cancer syndromes in the Netherlands. Upt...
Autores principales: | Dommering, Charlotte J., Henneman, Lidewij, van der Hout, Annemarie H., Jonker, Marianne A., Tops, Carli M. J., van den Ouweland, Ans M. W., van der Luijt, Rob B., Mensenkamp, Arjen R., Hogervorst, Frans B. L., Redeker, Egbert J. W., de Die-Smulders, Christine E. M., Moll, Annette C., Meijers-Heijboer, Hanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357498/ https://www.ncbi.nlm.nih.gov/pubmed/27826806 http://dx.doi.org/10.1007/s10689-016-9943-z |
Ejemplares similares
-
RB1 mutations and second primary malignancies after hereditary retinoblastoma
por: Dommering, Charlotte J., et al.
Publicado: (2011) -
With expanded carrier screening, founder populations run the risk of being overlooked
por: Mathijssen, Inge B., et al.
Publicado: (2017) -
Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes
por: Kooi, Irsan E., et al.
Publicado: (2016) -
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
por: Mohammadi, Leila, et al.
Publicado: (2009) -
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
por: Gómez García, Encarna B, et al.
Publicado: (2009)